Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — 2QFY18 Earnings Presentation
20 slides from Sunshine's earnings presentation, Nov 8, 2017
Slide 1: Sunshine
IN Sunshine
Slide 2: Earnings Presentation 2QFY18
Earnings Presentation 2QFY18 08th November 2017
Slide 3: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 4: Group Performance
Group Performance
Slide 5: Group at a Glance – 1HFY18 [Apr-Sep]
Group at a Glance – 1HFY18 [Apr-Sep] • LKR 10.3bn in Revenue; +8.9% YoY • LKR 1.1bn PAT; +24.2% YoY • PATMI of LKR 532m; +25.8% YoY Revenue - 1HFY18 Other, • Healthcare revenue; LKR 4.0bn; -2.0% YoY 2% FMCG, Healthcare • Agri revenue; LKR 3.8bn; +13.9% YoY. 23% , 38% 6.2m kg of palm oil, +1.9% YoY
Slide 6: Group at a Glance – 2QFY18 [Jul-Sep]
Group at a Glance – 2QFY18 [Jul-Sep] • LKR 5.1bn in Revenue; +5.4% YoY • LKR 608m PAT; +17.6% YoY • PATMI of LKR 307m; +41.8% YoY Revenue - 2QFY18 Other, • Healthcare revenue; LKR 2.0bn; -2.8% YoY 1% FMCG, • Agri revenue; LKR 1.8bn; +7.9% YoY. Healthcare 25% , 39% 3.2m kg of palm oil, -5.4% YoY. L
Slide 7: Group Financial Highlights
Group Financial Highlights 1H 1H Growth 2Q 2Q Growth LKR m FY18 FY17 % FY18 FY17 % Revenue 10,328 9,485 8.9% 5,128 4,864 5.4% EBIT 1,292 1,153 12.0% 622 634 -1.9% EBIT Margin 12.5% 12.2% 12.1% 13.0% Reported PAT 1,149 925 24.2% 608 517 17.6% PAT Margin 11.1% 9.8% 11.9% 10.6% Adjusted PAT* 1,022 900
Slide 8: 2Q Revenue Growth Trend
2Q Revenue Growth Trend • 5 Year CAGR of 10% 5 Yr CAGR: 10% 6,000 0.25 5,128 4,864 5,000 4,341 0.2 4,166 4,000 19% 3,498 0.15 LKR m 3,000 12% 0.1 2,000 7% 5% 0.05 1,000 4% - 0 2QFY14 2QFY15 2QFY16 2QFY17 2QFY18 Revenue Revenue Growth
Slide 9: 2Q Profitability
2Q Profitability 700 0.14 608 600 12% 0.12 517 11% 500 0.1 400 344 0.08 7% 8% 5% 300 0.06 236 LKR m 225 200 0.04 100 0.02 - 0 2QFY14 2QFY15 2QFY16 2QFY17 2QFY18 PAT PAT Margin • PAT at LKR 608m increased by 17.6% YoY • Healthcare margins contracted due to regulatory price control on essential drugs
Slide 10: Earnings Contribution – 2QFY18
Earnings Contribution – 2QFY18 PAT PATMI Healthcare, Healthcare, 24% Other, 20% 12% Other, FMCG, 39% LKR 608m LKR 307m 8% Agri, Agri, 60% 32% FMCG, 5%
Slide 11: Segment Performance 2Q FY18
Segment Performance 2Q FY18
Slide 12: Agri
Agri 1H 1H Growth 2Q 2Q Growth LKR m FY18 FY17 % FY18 FY17 % Revenue 3,766 3,307 13.9% 1,778 1,648 7.9% EBIT 743 664 11.9% 300 372 -19.4% EBIT Margin 19.7% 20.1% 16.9% 22.6% Profit for the period 743 548 35.7% 366 309 18.6% PAT Margin 19.7% 16.6% 20.6% 18.7% Highlights • Tea market NSA is higher in
Slide 13: FMCG
FMCG 1H 1H Growth 2Q 2Q Growth LKR m FY18 FY17 % FY18 FY17 % Revenue 2,410 1,899 27.0% 1,272 1,116 14.1% EBIT 147 180 -18.4% 78 132 -41.0% EBIT Margin 6.1% 9.5% 6.1% 11.9% Profit for the period 100 164 -38.6% 49 122 -59.3% PAT Margin 4.2% 8.6% 3.9% 10.9% Adjusted PAT* 100 139 -27.5% 49 97 -48.8% *Ad
Slide 14: Healthcare
Healthcare 1H 1H Growth 2Q 2Q Growth LKR m FY18 FY17 % FY18 FY17 % Revenue 3,960 4,040 -2.0% 2,025 2,083 -2.8% EBIT 245 284 -13.6% 109 158 -30.8% EBIT Margin 6.2% 7.0% 5.4% 7.6% Profit for the period 155 189 -17.9% 70 109 -35.6% PAT Margin 3.9% 4.7% 3.5% 5.3% Highlights • 2QFY18 Revenue contracted b
Slide 15: Healthcare Retail
Healthcare Retail 23 Outlets existing outlets in Colombo, including 11 express outlets Highlights • Continued focus on Beauty and Wellness sales helped margin expansion • Moderate growth in customer footfall • Consumer spending has been weak in 2Q
Slide 16: Other
Other Energy Packaging • Revenue of LKR 63m for • The operations seized and 2QFY18 against LKR 20m the property will be rented for the same period last out year, due to the commencement of the • Loss on discontinued second power plant operation of LKR 195m • EBIT of LKR 33m for 2Q • Gain of LKR 127m
Slide 17: Outlook
Outlook
Slide 18: Outlook for 3Q FY18
Outlook for 3Q FY18 Healthcare Agri • User training to promote • Tea NSA / Crop lower compared diagnostic brands in hospitals to last year • Further depreciation of LKR is • Palm Oil NSA will be better than expected 2Q • Focus on Beauty & Wellness • Next herd of cattle expected end brands to increas
Slide 19: Additional data for analysts
Additional data for analysts 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q LKR m FY14 FY14 FY14 FY15 FY15 FY15 FY15 FY16 FY16 FY16 FY17 FY17 FY17 FY17 FY17 FY18 FY18 Revenue 3,498 3,743 3,982 3,984 4,166 4,072 4,105 4,179 4,341 4,288 4,615 4,621 4,864 4,425 5,115 5,199 5,128 PAT 236 415 350 326
Slide 20: Thank you
Thank you For more information, Please visit our Investor Relations page http://www.sunshineholdings.lk/investor%20relations/index.php